CORPAY, INC.

CPAY

CIK 0001175454 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$1.25B
↑+20.7% +$214Mvs FY2024 (Q4)
Operating Income
$564M
↑+15.6% +$76Mvs FY2024 (Q4)
Net Income
$264M
↑+7.5% +$19Mvs FY2024 (Q4)
Gross Profit
$1.25B
↑+20.7% +$214Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
29/100
  • Profitability
    30ROIC 11.1% (10% = solid, 20%+ = moat)
  • Liquidity
    24Current Ratio 0.98 (above 1.5 = solid)
  • Leverage
    0D/E 2.58 (under 0.5 = conservative)
  • Efficiency
    0Asset Turnover 0.20x (1.0+ = capital-efficient)
  • Growth
    86Revenue YoY +20.7% (10% = solid, 25%+ = elite)
  • Margin Trend
    34Op Margin 45.2% · trend -0.9pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project CPAY's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -2.1%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$255.23
Total enterprise IV
$18.14B
Diluted shares
0.07B
Terminal PV
$12.78B (70% of total)
Year-5 FCF
$1.51B
YearProjected FCFDiscounted PV
+1$1.34B$1.22B
+2$1.38B$1.14B
+3$1.42B$1.07B
+4$1.46B$999M
+5$1.51B$935M
Terminal$20.58B$12.78B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$201M
investment in PP&E
Stock buybacks (TTM)
$783M
share count reduction
Stock-based comp (TTM)
$103M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$26.41B
everything owned
Stockholders' equity
$3.88B
shareholder claim
Net debt
$7.59B
LT debt minus cash

Recent performance · 65 quarters

Revenue↑+20.7% +$214M
$1.25B
Net Income↑+7.5% +$19M
$264M
Free Cash Flow↑+25.8% +$156M
$760M
Operating Margin↓-2.0pts
45.2%

Drill down